Day: June 17, 2024

Extendicare Announces June 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, June 17, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of June 2024, which is payable on July 15, 2024 to shareholders of record at the close of business on June 28, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors’ population. We operate a network of 123 long-term care homes...

Continue reading

Nature’s Sunshine Honored with Comparably Awards for Best Leadership Team and Best Career Growth

LEHI, Utah, June 17, 2024 (GLOBE NEWSWIRE) — Nature’s Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company offering high-quality herbal and nutritional products, has been recognized by Comparably with two prestigious workplace awards: Best Leadership Team—for a third consecutive year—and Best Career Growth. These honors highlight Nature’s Sunshine’s commitment to fostering an exceptional culture, engaging leaders to inspire excellence and providing opportunities for career growth. “We are very pleased to receive these awards from Comparably,” said Terrence Moorehead, Nature’s Sunshine CEO. “Our leadership team works tirelessly to create a culture of growth, collaboration, and success. This recognition is a testament to their efforts in driving our company forward while empowering our talented...

Continue reading

Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051

APR-1051 is a highly selective and potentially best-in-class oral WEE1 inhibitor Phase 1 ACESOT-1051 clinical trial is evaluating APR-1051 as monotherapy treatment in patients with significant unmet medical need Dosing of the first patient in the ACESOT-1051 study represents a key advancement in Aprea’s clinical pipeline DOYLESTOWN, Pa., June 17, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that the first patient has been dosed in the ACESOT-1051 Phase 1 study evaluating daily oral WEE1 inhibitor APR-1051 as monotherapy in advanced solid tumor patients with unmet medical need. APR-1051 was discovered and preclinically evaluated by Aprea’s team of chemists and scientists....

Continue reading

AMERANT BANK NAMES INDUSTRY VETERAN MIKE NURSEY AS CENTRAL FLORIDA MARKET PRESIDENT

On the heels of the recent opening of a Tampa regional office and a new banking center in the Westshore district, Nursey will lead Amerant’s ongoing expansion in Hillsborough County, Pinellas County and Central Florida as a whole Amerant Bank Mike Nursey, EVP, Central Florida Market President TAMPA, Fl, June 17, 2024 (GLOBE NEWSWIRE) — Amerant Bank, Florida’s bank of choice with a growing presence across the Greater Tampa area, has named industry veteran, Mike Nursey, as EVP, Central Florida Market President. Nursey will be responsible for the strategic execution of Amerant Bank’s growth strategy in Hillsborough, Pinellas counties as well as other key markets throughout Central Florida. “We are delighted to welcome Mike to the Amerant Bank team. His expertise in leading high-performing teams and client relationship management...

Continue reading

N2OFF: Save Foods is Expanding in Latin America with New Purchase Order from a Peruvian Customer

Neve Yarak, Israel, June 17, 2024 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced that its subsidiary Save Foods Ltd. received its first purchase order from a customer in Peru, a leading grower, packer and distributor of avocado. Save Foods’ first order from Peru is particularly exhilarating, given the remarkable growth of Peruvian agricultural exports on the global stage, from a modest $645 million in 2000 to an impressive estimated $10.5 billion in 2023. Save Foods’ eco- friendly solutions can be applied as a near and post-harvest solution for fresh produce to control pathogen contamination and prolong the shelf life of fresh produce while reducing the use of hazardous chemicals. The...

Continue reading

MegaWatt Metals Submitted Prospecting & Geochemical Survey Work Application for Benedict Mountains Uranium Property in Labrador’s Central Mineral Belt

Benedict Mountains Uranium Property hosts significant uranium resources Goals: confirm past results, explore known anomalies & support drill target selection Work planned for July 2024 Vancouver, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) — MegaWatt Lithium and Battery Metals Corp. (CSE:MEGA) (FSE: WR20) (OTCQB: WALRF) (the “Company“, “MegaWatt Metals” or “MegaWatt”) has submitted a work application with the Mineral Lands Division of Newfoundland and Labrador for exploration prospecting and geochemical surveying on the Company’s Benedict Mountains Uranium Property. The property hosts significant uranium resources in Labrador’s Central Mineral Belt. Work and planning are anticipated to commence July 2024 and end in October 2024, and can include “boot and hammer” prospecting, handheld/backpack...

Continue reading

iPower Inc. Announces $5 Million Registered Direct Offering

RANCHO CUCAMONGA, Calif., June 17, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven online retailer and supplier of consumer home, pet and garden products, as well as a provider of value-added ecommerce services, today announced that it has entered into a definitive securities purchase agreement for the purchase and sale of 2,083,334 shares of the Company’s common stock (or common stock equivalents) at a purchase price of $2.40 per share of common stock (or common stock equivalent) in a registered direct offering. In a concurrent private placement, the Company will issue warrants to purchase up to 2,083,334 shares of common stock. The warrants have an exercise price of $2.40 per share, will be immediately exercisable upon issuance and will have a term of five years following...

Continue reading

NuVista Receives TSX Approval for the Renewal of its Normal Course Issuer Bid

CALGARY, Alberta, June 17, 2024 (GLOBE NEWSWIRE) — NuVista Energy Ltd. (TSX:NVA, “NuVista” or the “Corporation”) announces that the Toronto Stock Exchange (the “TSX”) has approved the renewal of the Corporation’s normal course issuer bid (the “2024 NCIB”). Normal Course Issuer Bid Renewal Pursuant to the 2024 NCIB, NuVista may purchase for cancellation, from time to time, as it considers advisable, up to a maximum of 14,234,451 common shares of the Corporation. The 2024 NCIB will become effective on June 19, 2024 and will terminate on June 18, 2025 or such earlier time as the 2024 NCIB is completed or terminated at the option of NuVista. NuVista’s intention to continue its share buyback program is consistent with its strategy to continue its disciplined growth concurrently...

Continue reading

Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer

Ian Taylor, Ph.D. President of Research and Development at Arvinas, Inc. Angela Cacace, Ph.D. Chief Scientific Officer at Arvinas, Inc. NEW HAVEN, Conn., June 17, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced Ian Taylor, Ph.D. has been promoted to President of Research and Development and Angela Cacace, Ph.D. has also been promoted and will succeed Dr. Taylor as Chief Scientific Officer of the company. Dr. Taylor and Dr. Cacace will assume these new roles effective immediately and report to John Houston, Ph.D., Chairperson, President and Chief Executive Officer. “These promotions reflect the contributions of both Ian and Angela to our success at Arvinas, as well as their crucial roles...

Continue reading

GXO Receives SDCE 2024 Supply Chain Projects Award for Industry-first Humanoid Robotics Pilot

Industry-first pilot tested a humanoid robot in an actual warehouse environment Greenwich, Conn., June 17, 2024 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has been named the overall winner of Supply & Demand Chain Executive magazine’s (SDCE) 2024 Top Supply Chain Projects award for its industry-first pilot of humanoid robotics. This marks the third consecutive year that GXO has received a top project award and the first time it has been selected as an overall winner. “We’re delighted to be recognized by SDCE for our leadership in the development of humanoid technology to drive new efficiencies in the most labor-intensive parts of the supply chain,” said Adrian Stoch, Chief Automation Officer, GXO. “We have made the strategic decision...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.